It works by increasing the levels of certain chemical substances in the brain and thus helps in relieving the depressive symptoms.
Side effects
Major & minor side effects for Ellettra tablet 100 mg 2_10?s

Decreased interest in sexual intercourse severe

Abnormal ejaculation severe

Aggression or anger severe

Diarrhea severe

Drowsiness severe

Increased sweating severe

Trouble sleeping

Weight loss

Constipation

Painful urination

Uses of Ellettra tablet 100 mg 2_10?s
What is it prescribed for?

Depression
Ellettra tablet 100 mg 2_10?s is used to treat the symptoms of depression like feeling sad, irritable and devoid of energy.

Obsessive Compulsive Disorder
Ellettra tablet 100 mg 2_10?s is used to treat the symptoms of obsessive-compulsive disorder like repetitive thoughts and behaviour.

Panic disorder
Ellettra tablet 100 mg 2_10?s is used to treat the symptoms of panic disorder like sweating, breathing problem, weakness and numbness in hands.

Posttraumatic Stress Disorder
Ellettra tablet 100 mg 2_10?s is used to treat the symptoms of post-traumatic stress disorder which develop in a patient after a shocking or scary traumatic condition or an accident.

Premenstrual Dysphoric Disorder
Ellettra tablet 100 mg 2_10?s is used to treat the symptoms of premenstrual dysphoric disorder like severe depression, irritability, and tension before menstruation.

Social Anxiety Disorder
Ellettra tablet 100 mg 2_10?s is used to treat the symptoms of social anxiety disorder like extreme fear of being watched, red face or blushing, avoiding social situations and staying quite.

Concerns

Frequently asked questions

Onset of action
The peak effect of this medicine can be observed in 4.5 to 8.4 hours.

Duration of Effect
The effect of this medicine lasts for an average duration of 2 to 3 days.

Safe with Alchohol?
The effect of this medicine lasts for an average duration of 2 to 3 days.

Is it habit forming?
No habit forming tendencies were reported.

Usage in pregnancy?
This medicine is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine.

Usage while breast-feeding?
This medicine is known to excreted through the breast milk. It is not recommended for breastfeeding women unless absolutely necessary. Occasional side effects like sleeplessness, restlessness should be monitored.

When not to use?

Allergy
This medicine is not recommended for use if you have a known history of allergy to Ellettra tablet 100 mg 2_10?s .

Monoamine oxidase inhibitors
Ellettra tablet 100 mg 2_10?s is not recommended in the patients for at least 14 days after discontinuation of monoamine oxidase inhibitors.

Warnings

Warnings for special population

Pregnancy
This medicine is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine.

Breast-feeding
This medicine is known to excreted through the breast milk. It is not recommended for breastfeeding women unless absolutely necessary. Occasional side effects like sleeplessness, restlessness should be monitored.

General Warnings

Suicidal thoughts
This medicine may increase the risk of suicidal thoughts in the children, adolescents and young adults with the major depressive disorder or other psychiatric disorder. Patient’s caretakers should be educated about the symptoms of depression. Any symptoms of change in the behavior should be reported to the doctor.

Weight loss
Significant weight loss is observed in the patients treated with this medicine. Frequent monitoring of body weight is necessary. Any changes in the body weight should be reported to the doctor.

Abnormal bleeding
This medicine may increase the risk of bleeding especially in the patients receiving nonsteroidal anti-inflammatory drugs, aspirin, and warfarin. Monitoring of blood cells count should be performed. Any symptoms of abnormal bleeding should be reported to the doctor.

Low sodium levels
This medicine is known to lower the sodium levels in the body. This risk is more in the elderly population and in the patients receiving diuretics. Monitoring of sodium levels should be performed. Any symptoms of unsteadiness, headache, difficulty in concentration should be reported to the doctor.

Hypomania or mania
A Small proportion of patients receiving this medication experienced mania or hypomanic symptoms. Any symptoms of change in the behavior should be reported to the doctor immediately. Discontinue the treatment if the symptoms appear.

Seizures
Patients receiving this medication experienced seizures. It is not recommended in the patients with the history of unstable epilepsy. Discontinue the treatment if the symptoms appear.

Withdrawal symptoms
This medicine should not be discontinued abruptly. It may cause withdrawal symptoms like dizziness, sleep disturbances and anxiety. Do not stop the use of this medicine without consulting your doctor.

Impaired liver function
This medicine should be used with caution in the patients with the mild to moderate liver injury. It is not recommended in the patients with the severe liver injury.

Pediatric use
This medicine is not recommended for the children less than 6 years of age.

Dosage

Missed Dose
Take the missed dose as soon as you remember. However, if it is almost time for the next scheduled dose then the missed dose should be skipped.

Overdose
Contact a doctor immediately if an overdose is suspected. Symptoms of overdose may include a change in pulse rates, severe drowsiness, confusion, vomiting, hallucinations, convulsions, and fainting. Immediate medical intervention may be required if the overdose symptoms are severe.

Interactions
Interaction with Medicines

Ciprofloxacin moderate

Clozapine severe

Ondansetron severe

Nonsteroidal anti-inflammatory drugs moderate

Disease interactions

severe
This medicine may increase the risk of suicidal thoughts in the patients with depression. Patients caretakers should be educated about these symptoms. Any changes in the behavior should be reported to the doctor immediately.

moderate
This medicine may increase the risk of suicidal thoughts in the patients with depression. Patients caretakers should be educated about these symptoms. Any changes in the behavior should be reported to the doctor immediately.

Lab interactions

General Instructions

Take Ellettra tablet 100 mg 2_10?s as prescribed by the doctor. Do not take this medicine in larger or smaller quantities than recommended. The treatment should be started at lower doses and increase the dose gradually based on the response. Do not stop taking this medicine without informing your doctor.

Other details

Food timings: Information not available

Administration time: Information not available

Sleep inducing: Information not available

References

practo.com –
Sertraline [Internet].
Available from: https://www.practo.com/medicine-info/sertraline-253-api
[cited 18 september 2019].
18 april 2019

medlineplus.gov –
Sertraline [Internet].
Available from: https://medlineplus.gov/druginfo/meds/a697048.html
[cited 18 september 2019].
11 September 2019 Return to top

dailymed.nlm.nih.gov –
Sertraline [Internet].
Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee#LINK_0e306600-7ee1-4b8a-b4f9-5339975de4de
[cited 18 september 2019].
29 may 2013